<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35205286</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Microglia Influence Neurofilament Deposition in ALS iPSC-Derived Motor Neurons.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">241</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes13020241</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease in which upper and lower motor neuron loss is the primary phenotype, leading to muscle weakness and wasting, respiratory failure, and death. Although a portion of ALS cases are linked to one of over 50 unique genes, the vast majority of cases are sporadic in nature. However, the mechanisms underlying the motor neuron loss in either familial or sporadic ALS are not entirely clear. Here, we used induced pluripotent stem cells derived from a set of identical twin brothers discordant for ALS to assess the role of astrocytes and microglia on the expression and accumulation of neurofilament proteins in motor neurons. We found that motor neurons derived from the affected twin which exhibited increased transcript levels of all three neurofilament isoforms and increased expression of phosphorylated neurofilament puncta. We further found that treatment of the motor neurons with astrocyte-conditioned medium and microglial-conditioned medium significantly impacted neurofilament deposition. Together, these data suggest that glial-secreted factors can alter neurofilament pathology in ALS iPSC-derived motor neurons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Allison</LastName><ForeName>Reilly L</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0002-0074-4099</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adelman</LastName><ForeName>Jacob W</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0002-1847-3979</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrudan</LastName><ForeName>Jenica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genomic Science and Precision Medicine Center (GSPMC), Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urrutia</LastName><ForeName>Raul A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Genomic Science and Precision Medicine Center (GSPMC), Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Research, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmermann</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Genomic Science and Precision Medicine Center (GSPMC), Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Translational Sciences Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathison</LastName><ForeName>Angela J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-6763-2710</Identifier><AffiliationInfo><Affiliation>Genomic Science and Precision Medicine Center (GSPMC), Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Research, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebert</LastName><ForeName>Allison D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017077">Culture Media, Conditioned</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017077" MajorTopicYN="N">Culture Media, Conditioned</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007382" MajorTopicYN="N">Intermediate Filaments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA sequencing</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">anti-inflammatory</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">glia</Keyword><Keyword MajorTopicYN="N">induced pluripotent stem cells</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35205286</ArticleId><ArticleId IdType="pmc">PMC8871895</ArticleId><ArticleId IdType="doi">10.3390/genes13020241</ArticleId><ArticleId IdType="pii">genes13020241</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dhasmana S., Dhasmana A., Narula A.S., Jaggi M., Yallapu M.M., Chauhan S.C. The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder. Life Sci. 2022;288:120156. doi: 10.1016/j.lfs.2021.120156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.120156</ArticleId><ArticleId IdType="pubmed">34801512</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno Y., Amari M., Takatama M., Aizawa H., Mihara B., Okamoto K. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 2006;249:13&#x2013;18. doi: 10.1016/j.jns.2006.05.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.05.060</ArticleId><ArticleId IdType="pubmed">16820172</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Seminary E.R., Sison S.L., Ebert A.D. Modeling Protein Aggregation and the Heat Shock Response in ALS iPSC-Derived Motor Neurons. Front. Neurosci. 2018;12:86. doi: 10.3389/fnins.2018.00086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00086</ArticleId><ArticleId IdType="pmc">PMC5826239</ArticleId><ArticleId IdType="pubmed">29515358</ArticleId></ArticleIdList></Reference><Reference><Citation>Figlewicz D.A., Krizus A., Martinoli M.-G., Meininger V., Dib M., Rouleau G.A., Julien J.-P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 1994;3:1757&#x2013;1761. doi: 10.1093/hmg/3.10.1757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/3.10.1757</ArticleId><ArticleId IdType="pubmed">7849698</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings C.J., Mancini M.A., Antalffy B., DeFranco D.B., Orr H., Zoghbi H. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 1998;19:148&#x2013;154. doi: 10.1038/502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/502</ArticleId><ArticleId IdType="pubmed">9620770</ArticleId></ArticleIdList></Reference><Reference><Citation>Ii K., Ito H., Tanaka K., Hirano A. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neu-rodegenerative diseases and the elderly. J. Neuropathol. Exp. Neurol. 1997;56:125&#x2013;131. doi: 10.1097/00005072-199702000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199702000-00002</ArticleId><ArticleId IdType="pubmed">9034365</ArticleId></ArticleIdList></Reference><Reference><Citation>Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 1994;77:817&#x2013;827. doi: 10.1016/0092-8674(94)90131-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(94)90131-7</ArticleId><ArticleId IdType="pubmed">8004671</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu L.J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory M., Wong J., Takenouchi T., Hashimoto M., Masliah E. &#x3b1;-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress. Am. J. Pathol. 2000;157:401&#x2013;410. doi: 10.1016/S0002-9440(10)64553-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)64553-1</ArticleId><ArticleId IdType="pmc">PMC1850140</ArticleId><ArticleId IdType="pubmed">10934145</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosengren L.E., Karlsson J.E., Karlsson J.O., Persson L.I., Wikkelso C. Patients with amyotrophic lateral sclerosis and other neu-rodegenerative diseases have increased levels of neurofilament protein in CSF. J. Neurochem. 1996;67:2013&#x2013;2018. doi: 10.1046/j.1471-4159.1996.67052013.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1996.67052013.x</ArticleId><ArticleId IdType="pubmed">8863508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchi E., Bonetto V., Sorar&#xf9; G., Martinelli I., Parchi P., Liguori R., Mandrioli J. Neurofilaments in motor neuron disorders: Towards promising diagnostic and prognostic biomarkers. Mol. Neurodegener. 2020;15:58. doi: 10.1186/s13024-020-00406-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00406-3</ArticleId><ArticleId IdType="pmc">PMC7559190</ArticleId><ArticleId IdType="pubmed">33059698</ArticleId></ArticleIdList></Reference><Reference><Citation>Sferruzza G., Bosco L., Falzone Y.M., Russo T., Domi T., Quattrini A., Filippi M., Riva N. Neurofilament light chain as a biological marker for amyotrophic lateral sclerosis: A meta-analysis study. Amyotroph. Lateral Scler. Front. Degener. 2021:1&#x2013;12. doi: 10.1080/21678421.2021.2007952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.2007952</ArticleId><ArticleId IdType="pubmed">34874217</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderton B.H., Ayers M., Thorpe R. Neurofilaments from mammalian central and peripheral nerve share certain polypeptides. FEBS Lett. 1978;96:159&#x2013;163. doi: 10.1016/0014-5793(78)81083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(78)81083-7</ArticleId><ArticleId IdType="pubmed">729780</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien J.P., Mushynski W.E. The distribution of phosphorylation sites among identified proteolytic fragments of mammalian neurofilaments. J. Biol. Chem. 1983;258:4019&#x2013;4025. doi: 10.1016/S0021-9258(18)32770-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)32770-4</ArticleId><ArticleId IdType="pubmed">6339492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocquet A., Berges R., Frank R., Robert P., Peterson A.C., Eyer J. Neurofilaments Bind Tubulin and Modulate Its Polymerization. J. Neurosci. 2009;29:11043&#x2013;11054. doi: 10.1523/JNEUROSCI.1924-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1924-09.2009</ArticleId><ArticleId IdType="pmc">PMC6665525</ArticleId><ArticleId IdType="pubmed">19726663</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz M.L., Shneidman P.S., Bruce J., Schlaepfer W.W. Stabilization of neurofilament transcripts during postnatal development. Brain Res. Mol. Brain Res. 1994;27:215&#x2013;220. doi: 10.1016/0169-328X(94)90003-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0169-328X(94)90003-5</ArticleId><ArticleId IdType="pubmed">7534861</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu J.-M., Nguyen M.D., Julien J.-P. Late Onset Death of Motor Neurons in Mice Overexpressing Wild-Type Peripherin. J. Cell Biol. 1999;147:531&#x2013;544. doi: 10.1083/jcb.147.3.531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.147.3.531</ArticleId><ArticleId IdType="pmc">PMC2151189</ArticleId><ArticleId IdType="pubmed">15132161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kri&#x17e; J., Zhu Q., Julien J.-P., Padjen A.L. Electrophysiological properties of axons in mice lacking neurofilament subunit genes: Disparity between conduction velocity and axon diameter in absence of NF-H. Brain Res. 2000;885:32&#x2013;44. doi: 10.1016/S0006-8993(00)02899-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(00)02899-7</ArticleId><ArticleId IdType="pubmed">11121527</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Song J., Huang H., Chen H., Qian K. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells. Stem Cell Res. Ther. 2018;9:315. doi: 10.1186/s13287-018-1048-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-018-1048-1</ArticleId><ArticleId IdType="pmc">PMC6238404</ArticleId><ArticleId IdType="pubmed">30442180</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Qian K., Du Z., Cao J., Petersen A., Liu H., Blackbourn L.W., Huang C.-L., Errigo A., Yin Y., et al. Modeling ALS with iPSCs Reveals that Mutant SOD1 Misregulates Neurofilament Balance in Motor Neurons. Cell Stem Cell. 2014;14:796&#x2013;809. doi: 10.1016/j.stem.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.02.004</ArticleId><ArticleId IdType="pmc">PMC4230530</ArticleId><ArticleId IdType="pubmed">24704493</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K., Huang H., Peterson A., Hu B., Maragakis N.J., Ming G.-L., Chen H., Zhang S.-C. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo. Stem Cell Rep. 2017;8:843&#x2013;855. doi: 10.1016/j.stemcr.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerley S., Grierson A., Brownlees J., Thornhill P., Anderton B.H., Leigh P.N., Shaw C.E., Miller C. Glutamate Slows Axonal Transport of Neurofilaments in Transfected Neurons. J. Cell Biol. 2000;150:165&#x2013;176. doi: 10.1083/jcb.150.1.165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.150.1.165</ArticleId><ArticleId IdType="pmc">PMC2185569</ArticleId><ArticleId IdType="pubmed">10893265</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien J.-P. Amyotrophic Lateral Sclerosis: Unfolding the Toxicity of the Misfolded. Cell. 2001;104:581&#x2013;591. doi: 10.1016/S0092-8674(01)00244-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00244-6</ArticleId><ArticleId IdType="pubmed">11239414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasiene J., Yamanaka K. Glial Cells in Amyotrophic Lateral Sclerosis. Neurol. Res. Int. 2011;2011:718987. doi: 10.1155/2011/718987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/718987</ArticleId><ArticleId IdType="pmc">PMC3135155</ArticleId><ArticleId IdType="pubmed">21766027</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Devlin A.C., Chouhan A.K., Selvaraj B.T., Stavrou M., Burr K., Brivio V., He X., Mehta A.R., Story D., et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia. 2020;68:1046&#x2013;1064. doi: 10.1002/glia.23761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23761</ArticleId><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A., Ben-Dor I., Ottolenghi M., Turetsky T., Gil Y., Sweetat S., Perez L., Belzer V., Casden N., Steiner D., et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019;50:274&#x2013;289. doi: 10.1016/j.ebiom.2019.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.026</ArticleId><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice. Science. 2003;302:113&#x2013;117. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 2007;10:608&#x2013;614. doi: 10.1038/nn1885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1885</ArticleId><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto M.C., Muotri A.R., Mu Y., Smith A.M., Cezar G.G., Gage F.H. Non-Cell-Autonomous Effect of Human SOD1G37R Astrocytes on Motor Neurons Derived from Human Embryonic Stem Cells. Cell Stem Cell. 2008;3:649&#x2013;657. doi: 10.1016/j.stem.2008.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.10.001</ArticleId><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkler C., Ben-Zur T., Barhum Y., Offen D. Altered astrocytic response to activation in SOD1(G93A) mice and its implications on amyotrophic lateral sclerosis pathogenesis. Glia. 2013;61:312&#x2013;326. doi: 10.1002/glia.22428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22428</ArticleId><ArticleId IdType="pubmed">23280929</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller K.J., Restrepo C., Khan T., Dominique M.A., Fang T.C., Canter R.G., Roberts C.J., Miller K.R., Ransohoff R.M., Trojanowski J.Q., et al. Microglia-Mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 2018;21:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Deora V., Lee J.D., Albornoz E.A., McAlary L., Jagaraj C.J., Robertson A.A.B., Atkin J., Cooper M.A., Schroder K., Yerbury J., et al. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia. 2020;68:407&#x2013;421. doi: 10.1002/glia.23728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23728</ArticleId><ArticleId IdType="pubmed">31596526</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke B.E., Patani R. The microglial component of amyotrophic lateral sclerosis. Brain. 2020;143:3526&#x2013;3539. doi: 10.1093/brain/awaa309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa309</ArticleId><ArticleId IdType="pmc">PMC7805793</ArticleId><ArticleId IdType="pubmed">33427296</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., M&#xfc;nch A.E., Chung W.-S., Peterson T.C., et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Seminary E.R., Santarriaga S., Wheeler L., Mejaki M., Abrudan J., Demos W., Zimmermann M.T., Urrutia R.A., Fee D., Barkhaus P.E., et al. Motor Neuron Generation from iPSCs from Identical Twins Discordant for Amyotrophic Lateral Sclerosis. Cells. 2020;9:571. doi: 10.3390/cells9030571.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9030571</ArticleId><ArticleId IdType="pmc">PMC7140469</ArticleId><ArticleId IdType="pubmed">32121108</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y., C&#xf4;me J., Piskorowski R.A., Salah-Mohellibi N., Chevaleyre V., Peschanski M., Martinat C., Nedelec S. Combinatorial analysis of developmental cues efficiently converts human plu-ripotent stem cells into multiple neuronal subtypes. Nat. Biotechnol. 2015;33:89&#x2013;96. doi: 10.1038/nbt.3049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3049</ArticleId><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison R., Welby E., Khayrullina G., Burnett B., Ebert A. Viral mediated knockdown of GATA6 in SMA iPSC-derived astrocytes prevents motor neuron loss and microglial activation. bioRxiv. 2021 doi: 10.1101/2021.10.11.463972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.11.463972</ArticleId><ArticleId IdType="pubmed">35088910</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuade A., Coburn M., Tu C.H., Hasselmann J., Davtyan H., Blurton-Jones M. Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol. Neurodegener. 2018;13:67. doi: 10.1186/s13024-018-0297-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0297-x</ArticleId><ArticleId IdType="pmc">PMC6303871</ArticleId><ArticleId IdType="pubmed">30577865</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalari K.R., Nair A.A., Bhavsar J.D., O&#x2019;Brien D.R., Davila J.I., Bockol M.A., Nie J., Tang X., Baheti S., Doughty J.B., et al. MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing. BMC Bioinform. 2014;15:224. doi: 10.1186/1471-2105-15-224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-15-224</ArticleId><ArticleId IdType="pmc">PMC4228501</ArticleId><ArticleId IdType="pubmed">24972667</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson M.D., McCarthy D.J., Smyth G.K. EdgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139&#x2013;140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Santarriaga S., Luecke I., Ebert A. Methods in Molecular Biology. Springer-Nature; Berlin/Heidelberg, Germany: 2022. Detection of soluble and insoluble protein species in patient-derived iPSCs. in press .</Citation></Reference><Reference><Citation>Liao Z., Grimshaw R.S., Rosenstreich D.L. Identification of a specific interleukin 1 inhibitor in the urine of febrile patients. J. Exp. Med. 1984;159:126&#x2013;136. doi: 10.1084/jem.159.1.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.159.1.126</ArticleId><ArticleId IdType="pmc">PMC2187209</ArticleId><ArticleId IdType="pubmed">6607312</ArticleId></ArticleIdList></Reference><Reference><Citation>Shemer A., Scheyltjens I., Frumer G.R., Kim J.S., Grozovski J., Ayanaw S., Dassa B., Van Hove H., Chappell-Maor L., Boura-Halfon S., et al. Interleukin-10 Prevents Pathological Microglia Hyperactivation following Peripheral Endotoxin Challenge. Immunity. 2020;53:1033&#x2013;1049.e7. doi: 10.1016/j.immuni.2020.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.09.018</ArticleId><ArticleId IdType="pubmed">33049219</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology. 1968;18:841. doi: 10.1212/WNL.18.9.841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.18.9.841</ArticleId><ArticleId IdType="pubmed">4176657</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xf4;t&#xe9; F., Collard J.F., Julien J.P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis. Cell. 1993;73:35&#x2013;46. doi: 10.1016/0092-8674(93)90158-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90158-M</ArticleId><ArticleId IdType="pubmed">8462101</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Cork L.C., Griffin J.W., Cleveland D.W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell. 1993;73:23&#x2013;33. doi: 10.1016/0092-8674(93)90157-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90157-L</ArticleId><ArticleId IdType="pubmed">8462100</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson T.L., Bruijn L.I., Zhu Q., Anderson K.L., Anderson S.D., Julien J.-P., Cleveland D. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA. 1998;95:9631&#x2013;9636. doi: 10.1073/pnas.95.16.9631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.16.9631</ArticleId><ArticleId IdType="pmc">PMC21390</ArticleId><ArticleId IdType="pubmed">9689132</ArticleId></ArticleIdList></Reference><Reference><Citation>Couillard-Despres S., Zhu Q., Wong P.C., Price D.L., Cleveland D., Julien J.-P. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl. Acad. Sci. USA. 1998;95:9626&#x2013;9630. doi: 10.1073/pnas.95.16.9626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.16.9626</ArticleId><ArticleId IdType="pmc">PMC21389</ArticleId><ArticleId IdType="pubmed">9689131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J., Xu Z. Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis. Neurosci. Lett. 2000;281:72&#x2013;74. doi: 10.1016/S0304-3940(00)00808-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(00)00808-9</ArticleId><ArticleId IdType="pubmed">10686419</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D., Hawley Z.C.E., Strong M.J. Dysregulation of human NEFM and NEFH mRNA stability by ALS-linked miRNAs. Mol. Brain. 2018;11:43. doi: 10.1186/s13041-018-0386-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-018-0386-3</ArticleId><ArticleId IdType="pmc">PMC6054723</ArticleId><ArticleId IdType="pubmed">30029677</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahheydari H., Ragagnin A., Walker A., Toth R.P., Vidal M., Jagaraj C.J., Perri E.R., Konopka A., Sultana J.M., Atkin J.D. Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum. Front. Mol. Neurosci. 2017;10:119. doi: 10.3389/fnmol.2017.00119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00119</ArticleId><ArticleId IdType="pmc">PMC5423993</ArticleId><ArticleId IdType="pubmed">28539871</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A., Rao M., Veeranna, Nixon R.A. Neurofilaments and Neurofilament Proteins in Health and Disease. Cold Spring Harb. Perspect. Biol. 2017;9:a018309. doi: 10.1101/cshperspect.a018309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a018309</ArticleId><ArticleId IdType="pmc">PMC5378049</ArticleId><ArticleId IdType="pubmed">28373358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D.D., Bordey A. The astrocyte odyssey. Prog. Neurobiol. 2008;86:342&#x2013;367. doi: 10.1016/j.pneurobio.2008.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.09.015</ArticleId><ArticleId IdType="pmc">PMC2613184</ArticleId><ArticleId IdType="pubmed">18948166</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z.-Y., Jin W.-L., Xu Y., Jin M.-Z. Microglia in neurodegenerative diseases. Neural Regen. Res. 2021;16:270&#x2013;280. doi: 10.4103/1673-5374.290881.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.290881</ArticleId><ArticleId IdType="pmc">PMC7896205</ArticleId><ArticleId IdType="pubmed">32859774</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Li H., Hong C., Chen M., Yue T., Chen C., Wang Z., You Q., Li C., Weng Q., et al. ALS-Associated E478G Mutation in Human OPTN (Optineurin) Promotes Inflammation and Induces Neuronal Cell Death. Front. Immunol. 2018;9:2647. doi: 10.3389/fimmu.2018.02647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02647</ArticleId><ArticleId IdType="pmc">PMC6251386</ArticleId><ArticleId IdType="pubmed">30519240</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Harten A.C.M., Phatnani H., Przedborski S. Non-Cell-Autonomous pathogenic mechanisms in amyotrophic lateral sclerosis. Trends Neurosci. 2021;44:658&#x2013;668. doi: 10.1016/j.tins.2021.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2021.04.008</ArticleId><ArticleId IdType="pubmed">34006386</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>